VYNE
Vyne Therapeutics Inc
NASDAQ · Pharmaceuticals
$0.56
+0.00 (+0.48%)
Open$0.56
Previous Close$0.56
Day High$0.56
Day Low$0.56
52W High$23.09
52W Low$14.30
Volume—
Avg Volume449.4K
Market Cap18.84M
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+3,382.8% upside
Current
$0.56
$0.56
Target
$19.49
$19.49
$14.75
$19.49 avg
$26.42
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.79M | 2.72M | 3.05M |
| Net Income | 589.8K | 604.8K | 522.0K |
| Profit Margin | 21.2% | 22.3% | 17.1% |
| EBITDA | 828.7K | 831.2K | 1.01M |
| Free Cash Flow | 400.3K | 485.0K | 536.6K |
| Rev Growth | +10.4% | -5.6% | +23.8% |
| Debt/Equity | 0.66 | 0.54 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |